
Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR
Author(s) -
Carla Caparroz,
Alejandro Forner,
Jordi Rimola,
Anna Darnell,
Ángeles GarcíaCriado,
Juan Ramón Ayuso,
María Reig,
Jordi Bruix,
Carmen Ayuso
Publication year - 2022
Publication title -
radiology and oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.707
H-Index - 30
eISSN - 1581-3207
pISSN - 1318-2099
DOI - 10.2478/raon-2022-0024
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , gastroenterology , portal hypertension , liver function , portal venous pressure
The aim of the study was to analyze the association between the liver uptake of Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid (Gd-EOB-DTPA) in the hepatobiliary phase (HBP) in cirrhotic patients and the presence of clinically significant portal hypertension (CSPH), and how these features impact on hepatocellular carcinoma (HCC) detection in the HBP.